Cargando…

Comment on the risk of hepatocellular carcinoma with chronic hepatitis B infection in Sweden

Detalles Bibliográficos
Autores principales:	Singh, Satender Pal, Mondia, Nitisha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701461/ https://www.ncbi.nlm.nih.gov/pubmed/35811444 http://dx.doi.org/10.1002/hep4.2046

Ejemplares similares

Reply to ‘Comment on ‘Circulating Neutrophils in patients with hepatocellular carcinoma”
por: Chan, Stephen L., et al.
Publicado: (2018)

Comment on ‘Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?’
por: Liu, Yuying, et al.
Publicado: (2018)

Risk of hepatitis B virus-related hepatocellular carcinoma development is much higher in Koreans than in Taiwanese
por: Shim, Jae-Jun, et al.
Publicado: (2017)

Comment on “State of the Art in Magnetic Resonance Imaging of Hepatocellular Carcinoma”: The Role of DWI
por: Granata, Vincenza, et al.
Publicado: (2019)

Reply to Comments on “State of the Art in Magnetic Resonance Imaging of Hepatocellular Carcinoma”: The Role of DWI
por: Horvat, Natally, et al.
Publicado: (2019)

Comment on ‘MicroRNA-199b-5p attenuates TGF-β1-induced epithelial–mesenchymal transition in hepatocellular carcinoma’
por: Cristóbal, Ion, et al.
Publicado: (2018)

Chronic hepatitis B virus infection and the risk of hepatocellular carcinoma by age and country of origin in people living in Sweden: A national register study
por: Duberg, Ann‐Sofi, et al.
Publicado: (2022)

Update on the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Virus Infection
por: Hsu, Axel, et al.
Publicado: (2011)

Author response to: Comment on: Performance of non-invasive biomarkers compared with invasive methods for risk prediction of posthepatectomy liver failure in hepatocellular carcinoma
por: Hobeika, Christian, et al.
Publicado: (2022)

Reply to ‘Comment on ‘MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma’’
por: Zhou, Shao-jun, et al.
Publicado: (2018)

Comment on: Risk of Pancreatic Cancer in Relation to ABO Blood Group and Hepatitis C Virus Infection in Korea: A Case-Control Study
por: Kabir, Ali
Publicado: (2013)

Comment on: “UGT2B17 modifies drug response in chronic lymphocytic leukaemia”
por: Papamichos, Spyros I., et al.
Publicado: (2020)

Cholesterol and hepatocellular carcinoma risk: reliable and actionable?
por: Braillon, Alain
Publicado: (2021)

Reply to Comment on “UGT2B17 modifies drug response in chronic lymphocytic leukaemia”
por: Guillemette, Chantal, et al.
Publicado: (2020)

Reply to: Comments on “Nomograms based on inflammatory biomarkers for predicting tumor grade and micro-vascular invasion in stage I/II hepatocellular carcinoma”
por: Li, Peng, et al.
Publicado: (2019)

Hepatitis B Virus DNA Integration, Chronic Infections and Hepatocellular Carcinoma
por: Bousali, Maria, et al.
Publicado: (2021)

Risk Factors and Biomarkers for Chronic Hepatitis B Associated Hepatocellular Carcinoma
por: Pandyarajan, Vijay, et al.
Publicado: (2021)

A “sandwich” strategy for functional cure of chronic hepatitis B
por: Wang, Xuan-Yi, et al.
Publicado: (2018)

Porphyria and hepatocellular carcinoma
por: Pierach, C.A.
Publicado: (1987)

Inverse Association Between Chronic Hepatitis B Infection and Coronavirus Disease 2019 (COVID-19): Immune Exhaustion or Coincidence?
por: Anugwom, Chimaobi M, et al.
Publicado: (2020)

Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection
por: Xiang, Tiandan, et al.
Publicado: (2021)

The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection
por: Yu, Jung Hwan, et al.
Publicado: (2022)

Comment on the Article: Outcome of Sclerokeratoplasty in Devastating Sclerocorneal Infections
por: Srirampur, Arjun
Publicado: (2020)

Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B
por: Shin, Haneulsaem, et al.
Publicado: (2019)

Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?
por: Jang, Byoung Kuk
Publicado: (2016)

Association of Physical Activity with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
por: Chun, Ho Soo, et al.
Publicado: (2021)

Comment on: Validation of the Liver Transplant Risk Score in Europe
por: Suresan, Srutti, et al.
Publicado: (2022)

Comment on ‘From risk factors to explanation in public health’
por: Babu, Giridhara R.
Publicado: (2008)

Screening for Hepatocellular Carcinoma in Chronic Hepatitis B: An Update
por: Lok, James, et al.
Publicado: (2021)

Comment on: Conventional immunosuppression: the search for scientific evidence
por: Gandhi, Jagdeep Singh
Publicado: (2020)

Correspondence on Editorial regarding “Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease”
por: Sohn, Won, et al.
Publicado: (2023)

Hepatitis B Virus Reactivation in a Chronic Lymphocytic Leukemia Patient Treated with Ibrutinib
por: Choi, Jung Hye, et al.
Publicado: (2023)

Clinicopathologic characteristics and outcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection
por: Aljumah, Abdulrahman A., et al.
Publicado: (2018)

Diabetes Mellitus is a Risk Factor for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection in China
por: Li, Xu, et al.
Publicado: (2018)

Reply to Comments on ‘A functional polymorphism rs10830963 in melatonin receptor 1B associated with the risk of gestational diabetes mellitus’
por: Huang, Bo, et al.
Publicado: (2020)

READERS COMMENTS
por: Skaik, Younis Abed El-Wahhab
Publicado: (2011)

Development of hepatocellular carcinoma from various phases of chronic hepatitis B virus infection
por: Suzuki, Takanori, et al.
Publicado: (2021)

Hepatocellular Carcinoma in the Absence of Cirrhosis in a Child With Inactive Chronic Hepatitis B Infection
por: Rajan, Charanya, et al.
Publicado: (2021)

Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection
por: Lin, Chih-Lin, et al.
Publicado: (2023)

RNA binding protein-based risk score model for prognosis prediction of patients with hepatocellular carcinoma
por: Xu, Shengjun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_213ajnj2lvopcm5k1k2b9q5tc8